nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—CYP2C8—Levothyroxine—hypothyroidism	0.101	0.227	CbGbCtD
Regorafenib—CYP2C8—Liotrix—hypothyroidism	0.0987	0.222	CbGbCtD
Regorafenib—ABCB1—Levothyroxine—hypothyroidism	0.0685	0.154	CbGbCtD
Regorafenib—ABCB1—Liothyronine—hypothyroidism	0.0685	0.154	CbGbCtD
Regorafenib—ABCB1—Liotrix—hypothyroidism	0.0668	0.15	CbGbCtD
Regorafenib—CYP3A4—Levothyroxine—hypothyroidism	0.041	0.0922	CbGbCtD
Regorafenib—KIT—seminiferous tubule of testis—hypothyroidism	0.0115	0.0412	CbGeAlD
Regorafenib—RET—parathyroid gland—hypothyroidism	0.00859	0.0308	CbGeAlD
Regorafenib—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00544	0.0558	CcSEcCtD
Regorafenib—Myocardial infarction—Liothyronine—hypothyroidism	0.00541	0.0555	CcSEcCtD
Regorafenib—UGT1A1—urine—hypothyroidism	0.00529	0.019	CbGeAlD
Regorafenib—Hypocalcaemia—Liotrix—hypothyroidism	0.00389	0.0399	CcSEcCtD
Regorafenib—Hypertension—Liothyronine—hypothyroidism	0.00372	0.0382	CcSEcCtD
Regorafenib—DDR2—adrenal cortex—hypothyroidism	0.00331	0.0119	CbGeAlD
Regorafenib—DDR2—heart—hypothyroidism	0.0032	0.0115	CbGeAlD
Regorafenib—FRK—gonad—hypothyroidism	0.00306	0.011	CbGeAlD
Regorafenib—MAPK11—heart—hypothyroidism	0.00303	0.0109	CbGeAlD
Regorafenib—DDR2—cardiovascular system—hypothyroidism	0.00302	0.0108	CbGeAlD
Regorafenib—CYP2C19—urine—hypothyroidism	0.00287	0.0103	CbGeAlD
Regorafenib—Body temperature increased—Liothyronine—hypothyroidism	0.00278	0.0285	CcSEcCtD
Regorafenib—Weight decreased—Levothyroxine—hypothyroidism	0.00275	0.0282	CcSEcCtD
Regorafenib—Weight decreased—Dextrothyroxine—hypothyroidism	0.00275	0.0282	CcSEcCtD
Regorafenib—DDR2—pituitary gland—hypothyroidism	0.00267	0.00959	CbGeAlD
Regorafenib—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00267	0.0274	CcSEcCtD
Regorafenib—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00267	0.0274	CcSEcCtD
Regorafenib—NTRK1—testis—hypothyroidism	0.00266	0.00954	CbGeAlD
Regorafenib—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00266	0.0272	CcSEcCtD
Regorafenib—Myocardial infarction—Levothyroxine—hypothyroidism	0.00266	0.0272	CcSEcCtD
Regorafenib—DDR2—adrenal gland—hypothyroidism	0.00239	0.00857	CbGeAlD
Regorafenib—Hypokalaemia—Liotrix—hypothyroidism	0.00235	0.0241	CcSEcCtD
Regorafenib—DDR2—thyroid gland—hypothyroidism	0.0023	0.00827	CbGeAlD
Regorafenib—MAPK11—adrenal gland—hypothyroidism	0.00226	0.00812	CbGeAlD
Regorafenib—BRAF—heart—hypothyroidism	0.00226	0.00812	CbGeAlD
Regorafenib—EPHX2—adrenal cortex—hypothyroidism	0.00224	0.00802	CbGeAlD
Regorafenib—DDR2—female gonad—hypothyroidism	0.00223	0.00799	CbGeAlD
Regorafenib—CYP2C9—urine—hypothyroidism	0.00222	0.00797	CbGeAlD
Regorafenib—FRK—testis—hypothyroidism	0.0022	0.0079	CbGeAlD
Regorafenib—MAPK11—thyroid gland—hypothyroidism	0.00219	0.00784	CbGeAlD
Regorafenib—EPHX2—heart—hypothyroidism	0.00216	0.00776	CbGeAlD
Regorafenib—Alopecia—Levothyroxine—hypothyroidism	0.00215	0.022	CcSEcCtD
Regorafenib—Alopecia—Dextrothyroxine—hypothyroidism	0.00215	0.022	CcSEcCtD
Regorafenib—MAPK11—female gonad—hypothyroidism	0.00211	0.00758	CbGeAlD
Regorafenib—FRK—liver—hypothyroidism	0.00208	0.00747	CbGeAlD
Regorafenib—Weight decreased—Liotrix—hypothyroidism	0.00202	0.0207	CcSEcCtD
Regorafenib—FLT4—adrenal cortex—hypothyroidism	0.00202	0.00723	CbGeAlD
Regorafenib—Tremor—Dextrothyroxine—hypothyroidism	0.00198	0.0204	CcSEcCtD
Regorafenib—Tremor—Levothyroxine—hypothyroidism	0.00198	0.0204	CcSEcCtD
Regorafenib—DDR2—testis—hypothyroidism	0.00198	0.00709	CbGeAlD
Regorafenib—Acute coronary syndrome—Liotrix—hypothyroidism	0.00197	0.0202	CcSEcCtD
Regorafenib—Myocardial infarction—Liotrix—hypothyroidism	0.00195	0.02	CcSEcCtD
Regorafenib—FLT4—heart—hypothyroidism	0.00195	0.00699	CbGeAlD
Regorafenib—FGFR1—heart—hypothyroidism	0.00192	0.0069	CbGeAlD
Regorafenib—BRAF—pituitary gland—hypothyroidism	0.00189	0.00678	CbGeAlD
Regorafenib—MAPK11—testis—hypothyroidism	0.00187	0.00672	CbGeAlD
Regorafenib—DDR2—liver—hypothyroidism	0.00187	0.0067	CbGeAlD
Regorafenib—FLT4—cardiovascular system—hypothyroidism	0.00184	0.0066	CbGeAlD
Regorafenib—DDR2—cerebellum—hypothyroidism	0.00182	0.00655	CbGeAlD
Regorafenib—EPHX2—pituitary gland—hypothyroidism	0.00181	0.00648	CbGeAlD
Regorafenib—MAPK11—cerebellum—hypothyroidism	0.00173	0.0062	CbGeAlD
Regorafenib—RET—heart—hypothyroidism	0.00172	0.00618	CbGeAlD
Regorafenib—CYP3A4—urine—hypothyroidism	0.00169	0.00608	CbGeAlD
Regorafenib—BRAF—adrenal gland—hypothyroidism	0.00169	0.00606	CbGeAlD
Regorafenib—BRAF—blood—hypothyroidism	0.00169	0.00606	CbGeAlD
Regorafenib—EPHA2—adrenal cortex—hypothyroidism	0.00166	0.00596	CbGeAlD
Regorafenib—BRAF—thyroid gland—hypothyroidism	0.00163	0.00585	CbGeAlD
Regorafenib—TEK—adrenal cortex—hypothyroidism	0.00162	0.00582	CbGeAlD
Regorafenib—EPHX2—adrenal gland—hypothyroidism	0.00161	0.00579	CbGeAlD
Regorafenib—EPHX2—blood—hypothyroidism	0.00161	0.00579	CbGeAlD
Regorafenib—EPHA2—heart—hypothyroidism	0.00161	0.00577	CbGeAlD
Regorafenib—FGFR1—pituitary gland—hypothyroidism	0.00161	0.00577	CbGeAlD
Regorafenib—Alopecia—Liotrix—hypothyroidism	0.00158	0.0162	CcSEcCtD
Regorafenib—BRAF—female gonad—hypothyroidism	0.00157	0.00565	CbGeAlD
Regorafenib—TEK—heart—hypothyroidism	0.00157	0.00563	CbGeAlD
Regorafenib—FLT1—adrenal cortex—hypothyroidism	0.00157	0.00562	CbGeAlD
Regorafenib—RAF1—adrenal cortex—hypothyroidism	0.00156	0.00559	CbGeAlD
Regorafenib—EPHX2—thyroid gland—hypothyroidism	0.00156	0.00559	CbGeAlD
Regorafenib—FGFR2—cardiovascular system—hypothyroidism	0.00154	0.00554	CbGeAlD
Regorafenib—EPHA2—cardiovascular system—hypothyroidism	0.00152	0.00544	CbGeAlD
Regorafenib—FLT1—heart—hypothyroidism	0.00152	0.00544	CbGeAlD
Regorafenib—RAF1—heart—hypothyroidism	0.00151	0.00541	CbGeAlD
Regorafenib—EPHX2—female gonad—hypothyroidism	0.0015	0.0054	CbGeAlD
Regorafenib—Fatigue—Levothyroxine—hypothyroidism	0.00149	0.0153	CcSEcCtD
Regorafenib—Fatigue—Dextrothyroxine—hypothyroidism	0.00149	0.0153	CcSEcCtD
Regorafenib—TEK—cardiovascular system—hypothyroidism	0.00148	0.00531	CbGeAlD
Regorafenib—Tremor—Liotrix—hypothyroidism	0.00146	0.015	CcSEcCtD
Regorafenib—FLT4—adrenal gland—hypothyroidism	0.00146	0.00522	CbGeAlD
Regorafenib—FLT4—blood—hypothyroidism	0.00145	0.00522	CbGeAlD
Regorafenib—RET—pituitary gland—hypothyroidism	0.00144	0.00516	CbGeAlD
Regorafenib—FGFR1—adrenal gland—hypothyroidism	0.00144	0.00515	CbGeAlD
Regorafenib—FLT1—cardiovascular system—hypothyroidism	0.00143	0.00513	CbGeAlD
Regorafenib—RAF1—cardiovascular system—hypothyroidism	0.00142	0.0051	CbGeAlD
Regorafenib—PDGFRA—heart—hypothyroidism	0.00142	0.0051	CbGeAlD
Regorafenib—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00141	0.0145	CcSEcCtD
Regorafenib—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00141	0.0145	CcSEcCtD
Regorafenib—FLT4—thyroid gland—hypothyroidism	0.0014	0.00504	CbGeAlD
Regorafenib—BRAF—testis—hypothyroidism	0.0014	0.00501	CbGeAlD
Regorafenib—FGFR1—thyroid gland—hypothyroidism	0.00139	0.00497	CbGeAlD
Regorafenib—Body temperature increased—Levothyroxine—hypothyroidism	0.00137	0.014	CcSEcCtD
Regorafenib—Abdominal pain—Levothyroxine—hypothyroidism	0.00137	0.014	CcSEcCtD
Regorafenib—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00137	0.014	CcSEcCtD
Regorafenib—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00137	0.014	CcSEcCtD
Regorafenib—FLT4—female gonad—hypothyroidism	0.00136	0.00487	CbGeAlD
Regorafenib—Hypertension—Liotrix—hypothyroidism	0.00135	0.0138	CcSEcCtD
Regorafenib—EPHA2—pituitary gland—hypothyroidism	0.00134	0.00482	CbGeAlD
Regorafenib—PDGFRA—cardiovascular system—hypothyroidism	0.00134	0.00481	CbGeAlD
Regorafenib—FGFR1—female gonad—hypothyroidism	0.00134	0.0048	CbGeAlD
Regorafenib—EPHX2—testis—hypothyroidism	0.00133	0.00479	CbGeAlD
Regorafenib—KDR—adrenal cortex—hypothyroidism	0.00132	0.00475	CbGeAlD
Regorafenib—BRAF—liver—hypothyroidism	0.00132	0.00474	CbGeAlD
Regorafenib—TEK—pituitary gland—hypothyroidism	0.00131	0.0047	CbGeAlD
Regorafenib—FLT1—gonad—hypothyroidism	0.0013	0.00466	CbGeAlD
Regorafenib—RAF1—gonad—hypothyroidism	0.00129	0.00463	CbGeAlD
Regorafenib—BRAF—cerebellum—hypothyroidism	0.00129	0.00463	CbGeAlD
Regorafenib—RET—adrenal gland—hypothyroidism	0.00128	0.00461	CbGeAlD
Regorafenib—RET—blood—hypothyroidism	0.00128	0.00461	CbGeAlD
Regorafenib—KDR—heart—hypothyroidism	0.00128	0.0046	CbGeAlD
Regorafenib—FLT1—pituitary gland—hypothyroidism	0.00127	0.00454	CbGeAlD
Regorafenib—Infection—Liotrix—hypothyroidism	0.00126	0.013	CcSEcCtD
Regorafenib—EPHX2—liver—hypothyroidism	0.00126	0.00453	CbGeAlD
Regorafenib—RAF1—pituitary gland—hypothyroidism	0.00126	0.00452	CbGeAlD
Regorafenib—Asthenia—Levothyroxine—hypothyroidism	0.00124	0.0127	CcSEcCtD
Regorafenib—Asthenia—Dextrothyroxine—hypothyroidism	0.00124	0.0127	CcSEcCtD
Regorafenib—RET—thyroid gland—hypothyroidism	0.00124	0.00445	CbGeAlD
Regorafenib—EPHX2—cerebellum—hypothyroidism	0.00123	0.00442	CbGeAlD
Regorafenib—FGFR2—adrenal gland—hypothyroidism	0.00122	0.00438	CbGeAlD
Regorafenib—FGFR2—blood—hypothyroidism	0.00122	0.00438	CbGeAlD
Regorafenib—PDGFRA—gonad—hypothyroidism	0.00122	0.00436	CbGeAlD
Regorafenib—KDR—cardiovascular system—hypothyroidism	0.00121	0.00434	CbGeAlD
Regorafenib—FLT4—testis—hypothyroidism	0.0012	0.00432	CbGeAlD
Regorafenib—EPHA2—adrenal gland—hypothyroidism	0.0012	0.0043	CbGeAlD
Regorafenib—EPHA2—blood—hypothyroidism	0.0012	0.0043	CbGeAlD
Regorafenib—FGFR1—testis—hypothyroidism	0.00119	0.00426	CbGeAlD
Regorafenib—Diarrhoea—Levothyroxine—hypothyroidism	0.00118	0.0121	CcSEcCtD
Regorafenib—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00118	0.0121	CcSEcCtD
Regorafenib—FGFR2—thyroid gland—hypothyroidism	0.00118	0.00423	CbGeAlD
Regorafenib—TEK—adrenal gland—hypothyroidism	0.00117	0.0042	CbGeAlD
Regorafenib—TEK—blood—hypothyroidism	0.00117	0.0042	CbGeAlD
Regorafenib—EPHA2—thyroid gland—hypothyroidism	0.00116	0.00415	CbGeAlD
Regorafenib—UGT1A9—liver—hypothyroidism	0.00115	0.00414	CbGeAlD
Regorafenib—PDGFRB—adrenal cortex—hypothyroidism	0.00115	0.00411	CbGeAlD
Regorafenib—FGFR2—female gonad—hypothyroidism	0.00114	0.00408	CbGeAlD
Regorafenib—FLT4—liver—hypothyroidism	0.00114	0.00408	CbGeAlD
Regorafenib—KIT—heart—hypothyroidism	0.00114	0.00407	CbGeAlD
Regorafenib—FLT1—adrenal gland—hypothyroidism	0.00113	0.00406	CbGeAlD
Regorafenib—FLT1—blood—hypothyroidism	0.00113	0.00406	CbGeAlD
Regorafenib—TEK—thyroid gland—hypothyroidism	0.00113	0.00405	CbGeAlD
Regorafenib—RAF1—adrenal gland—hypothyroidism	0.00112	0.00404	CbGeAlD
Regorafenib—RAF1—blood—hypothyroidism	0.00112	0.00403	CbGeAlD
Regorafenib—FGFR1—liver—hypothyroidism	0.00112	0.00403	CbGeAlD
Regorafenib—EPHA2—female gonad—hypothyroidism	0.00112	0.00401	CbGeAlD
Regorafenib—PDGFRB—heart—hypothyroidism	0.00111	0.00398	CbGeAlD
Regorafenib—Decreased appetite—Liotrix—hypothyroidism	0.00111	0.0113	CcSEcCtD
Regorafenib—Vomiting—Dextrothyroxine—hypothyroidism	0.0011	0.0113	CcSEcCtD
Regorafenib—Vomiting—Levothyroxine—hypothyroidism	0.0011	0.0113	CcSEcCtD
Regorafenib—FGFR1—cerebellum—hypothyroidism	0.0011	0.00393	CbGeAlD
Regorafenib—Fatigue—Liotrix—hypothyroidism	0.0011	0.0112	CcSEcCtD
Regorafenib—FLT1—thyroid gland—hypothyroidism	0.00109	0.00392	CbGeAlD
Regorafenib—TEK—female gonad—hypothyroidism	0.00109	0.00391	CbGeAlD
Regorafenib—Rash—Levothyroxine—hypothyroidism	0.00109	0.0112	CcSEcCtD
Regorafenib—Rash—Dextrothyroxine—hypothyroidism	0.00109	0.0112	CcSEcCtD
Regorafenib—Dermatitis—Levothyroxine—hypothyroidism	0.00109	0.0112	CcSEcCtD
Regorafenib—Dermatitis—Dextrothyroxine—hypothyroidism	0.00109	0.0112	CcSEcCtD
Regorafenib—RAF1—thyroid gland—hypothyroidism	0.00109	0.00389	CbGeAlD
Regorafenib—Headache—Dextrothyroxine—hypothyroidism	0.00108	0.0111	CcSEcCtD
Regorafenib—Headache—Levothyroxine—hypothyroidism	0.00108	0.0111	CcSEcCtD
Regorafenib—KIT—cardiovascular system—hypothyroidism	0.00107	0.00384	CbGeAlD
Regorafenib—KDR—pituitary gland—hypothyroidism	0.00107	0.00384	CbGeAlD
Regorafenib—RET—testis—hypothyroidism	0.00106	0.00381	CbGeAlD
Regorafenib—PDGFRA—adrenal gland—hypothyroidism	0.00106	0.0038	CbGeAlD
Regorafenib—PDGFRA—blood—hypothyroidism	0.00106	0.0038	CbGeAlD
Regorafenib—FLT1—female gonad—hypothyroidism	0.00105	0.00378	CbGeAlD
Regorafenib—RAF1—female gonad—hypothyroidism	0.00105	0.00376	CbGeAlD
Regorafenib—PDGFRB—cardiovascular system—hypothyroidism	0.00105	0.00375	CbGeAlD
Regorafenib—Gastrointestinal pain—Liotrix—hypothyroidism	0.00104	0.0107	CcSEcCtD
Regorafenib—Nausea—Dextrothyroxine—hypothyroidism	0.00103	0.0105	CcSEcCtD
Regorafenib—Nausea—Levothyroxine—hypothyroidism	0.00103	0.0105	CcSEcCtD
Regorafenib—PDGFRA—thyroid gland—hypothyroidism	0.00102	0.00367	CbGeAlD
Regorafenib—ABL1—adrenal cortex—hypothyroidism	0.00102	0.00367	CbGeAlD
Regorafenib—UGT1A1—blood—hypothyroidism	0.00101	0.00363	CbGeAlD
Regorafenib—FGFR2—testis—hypothyroidism	0.00101	0.00362	CbGeAlD
Regorafenib—Abdominal pain—Liotrix—hypothyroidism	0.00101	0.0103	CcSEcCtD
Regorafenib—Body temperature increased—Liotrix—hypothyroidism	0.00101	0.0103	CcSEcCtD
Regorafenib—EPHA2—testis—hypothyroidism	0.000992	0.00356	CbGeAlD
Regorafenib—PDGFRA—female gonad—hypothyroidism	0.000989	0.00355	CbGeAlD
Regorafenib—ABL1—heart—hypothyroidism	0.000989	0.00355	CbGeAlD
Regorafenib—RET—cerebellum—hypothyroidism	0.000981	0.00352	CbGeAlD
Regorafenib—KIT—gonad—hypothyroidism	0.000972	0.00349	CbGeAlD
Regorafenib—TEK—testis—hypothyroidism	0.000968	0.00347	CbGeAlD
Regorafenib—KDR—adrenal gland—hypothyroidism	0.000956	0.00343	CbGeAlD
Regorafenib—KDR—blood—hypothyroidism	0.000956	0.00343	CbGeAlD
Regorafenib—FGFR2—liver—hypothyroidism	0.000954	0.00342	CbGeAlD
Regorafenib—PDGFRB—gonad—hypothyroidism	0.00095	0.00341	CbGeAlD
Regorafenib—KIT—pituitary gland—hypothyroidism	0.000949	0.0034	CbGeAlD
Regorafenib—EPHA2—liver—hypothyroidism	0.000938	0.00336	CbGeAlD
Regorafenib—FLT1—testis—hypothyroidism	0.000936	0.00336	CbGeAlD
Regorafenib—ABL1—cardiovascular system—hypothyroidism	0.000933	0.00335	CbGeAlD
Regorafenib—FGFR2—cerebellum—hypothyroidism	0.000932	0.00334	CbGeAlD
Regorafenib—RAF1—testis—hypothyroidism	0.00093	0.00334	CbGeAlD
Regorafenib—PDGFRB—pituitary gland—hypothyroidism	0.000927	0.00332	CbGeAlD
Regorafenib—KDR—thyroid gland—hypothyroidism	0.000923	0.00331	CbGeAlD
Regorafenib—TEK—liver—hypothyroidism	0.000915	0.00328	CbGeAlD
Regorafenib—Asthenia—Liotrix—hypothyroidism	0.000912	0.00936	CcSEcCtD
Regorafenib—TEK—cerebellum—hypothyroidism	0.000894	0.00321	CbGeAlD
Regorafenib—KDR—female gonad—hypothyroidism	0.000892	0.0032	CbGeAlD
Regorafenib—FLT1—liver—hypothyroidism	0.000885	0.00317	CbGeAlD
Regorafenib—RAF1—liver—hypothyroidism	0.000879	0.00316	CbGeAlD
Regorafenib—PDGFRA—testis—hypothyroidism	0.000877	0.00315	CbGeAlD
Regorafenib—Diarrhoea—Liotrix—hypothyroidism	0.00087	0.00892	CcSEcCtD
Regorafenib—FLT1—cerebellum—hypothyroidism	0.000864	0.0031	CbGeAlD
Regorafenib—RAF1—cerebellum—hypothyroidism	0.000859	0.00308	CbGeAlD
Regorafenib—KIT—adrenal gland—hypothyroidism	0.000848	0.00304	CbGeAlD
Regorafenib—KIT—blood—hypothyroidism	0.000847	0.00304	CbGeAlD
Regorafenib—ABL1—gonad—hypothyroidism	0.000847	0.00304	CbGeAlD
Regorafenib—PDGFRA—liver—hypothyroidism	0.000829	0.00297	CbGeAlD
Regorafenib—PDGFRB—adrenal gland—hypothyroidism	0.000828	0.00297	CbGeAlD
Regorafenib—PDGFRB—blood—hypothyroidism	0.000828	0.00297	CbGeAlD
Regorafenib—ABL1—pituitary gland—hypothyroidism	0.000826	0.00296	CbGeAlD
Regorafenib—KIT—thyroid gland—hypothyroidism	0.000818	0.00293	CbGeAlD
Regorafenib—PDGFRA—cerebellum—hypothyroidism	0.00081	0.00291	CbGeAlD
Regorafenib—Vomiting—Liotrix—hypothyroidism	0.000809	0.00829	CcSEcCtD
Regorafenib—Rash—Liotrix—hypothyroidism	0.000802	0.00822	CcSEcCtD
Regorafenib—Dermatitis—Liotrix—hypothyroidism	0.000801	0.00821	CcSEcCtD
Regorafenib—PDGFRB—thyroid gland—hypothyroidism	0.000799	0.00287	CbGeAlD
Regorafenib—Headache—Liotrix—hypothyroidism	0.000797	0.00817	CcSEcCtD
Regorafenib—KDR—testis—hypothyroidism	0.000791	0.00284	CbGeAlD
Regorafenib—UGT1A1—liver—hypothyroidism	0.000791	0.00284	CbGeAlD
Regorafenib—KIT—female gonad—hypothyroidism	0.00079	0.00284	CbGeAlD
Regorafenib—PDGFRB—female gonad—hypothyroidism	0.000772	0.00277	CbGeAlD
Regorafenib—Nausea—Liotrix—hypothyroidism	0.000755	0.00775	CcSEcCtD
Regorafenib—KDR—liver—hypothyroidism	0.000748	0.00268	CbGeAlD
Regorafenib—ABL1—adrenal gland—hypothyroidism	0.000738	0.00265	CbGeAlD
Regorafenib—ABL1—blood—hypothyroidism	0.000738	0.00265	CbGeAlD
Regorafenib—KDR—cerebellum—hypothyroidism	0.00073	0.00262	CbGeAlD
Regorafenib—ABL1—thyroid gland—hypothyroidism	0.000712	0.00255	CbGeAlD
Regorafenib—KIT—testis—hypothyroidism	0.000701	0.00251	CbGeAlD
Regorafenib—ABL1—female gonad—hypothyroidism	0.000688	0.00247	CbGeAlD
Regorafenib—PDGFRB—testis—hypothyroidism	0.000685	0.00246	CbGeAlD
Regorafenib—KIT—liver—hypothyroidism	0.000663	0.00238	CbGeAlD
Regorafenib—KIT—cerebellum—hypothyroidism	0.000647	0.00232	CbGeAlD
Regorafenib—PDGFRB—liver—hypothyroidism	0.000647	0.00232	CbGeAlD
Regorafenib—ABCG2—adrenal cortex—hypothyroidism	0.000645	0.00231	CbGeAlD
Regorafenib—PDGFRB—cerebellum—hypothyroidism	0.000632	0.00227	CbGeAlD
Regorafenib—ABCG2—heart—hypothyroidism	0.000623	0.00224	CbGeAlD
Regorafenib—ABL1—testis—hypothyroidism	0.00061	0.00219	CbGeAlD
Regorafenib—CYP2B6—adrenal cortex—hypothyroidism	0.000595	0.00213	CbGeAlD
Regorafenib—ABL1—liver—hypothyroidism	0.000577	0.00207	CbGeAlD
Regorafenib—CYP2B6—heart—hypothyroidism	0.000575	0.00206	CbGeAlD
Regorafenib—CYP2C9—heart—hypothyroidism	0.000569	0.00204	CbGeAlD
Regorafenib—ABL1—cerebellum—hypothyroidism	0.000564	0.00202	CbGeAlD
Regorafenib—CYP2C19—blood—hypothyroidism	0.000548	0.00197	CbGeAlD
Regorafenib—CYP2B6—cardiovascular system—hypothyroidism	0.000543	0.00195	CbGeAlD
Regorafenib—CYP2C9—cardiovascular system—hypothyroidism	0.000537	0.00193	CbGeAlD
Regorafenib—CYP2C8—pituitary gland—hypothyroidism	0.000536	0.00192	CbGeAlD
Regorafenib—ABCG2—pituitary gland—hypothyroidism	0.000521	0.00187	CbGeAlD
Regorafenib—CYP2B6—gonad—hypothyroidism	0.000493	0.00177	CbGeAlD
Regorafenib—CYP2C8—blood—hypothyroidism	0.000478	0.00172	CbGeAlD
Regorafenib—ABCG2—adrenal gland—hypothyroidism	0.000465	0.00167	CbGeAlD
Regorafenib—ABCG2—blood—hypothyroidism	0.000465	0.00167	CbGeAlD
Regorafenib—ABCG2—thyroid gland—hypothyroidism	0.000449	0.00161	CbGeAlD
Regorafenib—ABCG2—female gonad—hypothyroidism	0.000434	0.00156	CbGeAlD
Regorafenib—CYP2B6—adrenal gland—hypothyroidism	0.000429	0.00154	CbGeAlD
Regorafenib—CYP2B6—blood—hypothyroidism	0.000429	0.00154	CbGeAlD
Regorafenib—CYP2C19—liver—hypothyroidism	0.000429	0.00154	CbGeAlD
Regorafenib—CYP2C9—blood—hypothyroidism	0.000425	0.00152	CbGeAlD
Regorafenib—CYP2C8—testis—hypothyroidism	0.000396	0.00142	CbGeAlD
Regorafenib—ABCG2—testis—hypothyroidism	0.000385	0.00138	CbGeAlD
Regorafenib—CYP2C8—liver—hypothyroidism	0.000374	0.00134	CbGeAlD
Regorafenib—ABCG2—liver—hypothyroidism	0.000364	0.00131	CbGeAlD
Regorafenib—ABCG2—cerebellum—hypothyroidism	0.000355	0.00127	CbGeAlD
Regorafenib—CYP2B6—testis—hypothyroidism	0.000355	0.00127	CbGeAlD
Regorafenib—CYP2B6—liver—hypothyroidism	0.000336	0.0012	CbGeAlD
Regorafenib—CYP2C9—liver—hypothyroidism	0.000332	0.00119	CbGeAlD
Regorafenib—CYP3A4—blood—hypothyroidism	0.000324	0.00116	CbGeAlD
Regorafenib—ABCB1—adrenal cortex—hypothyroidism	0.000318	0.00114	CbGeAlD
Regorafenib—ABCB1—heart—hypothyroidism	0.000307	0.0011	CbGeAlD
Regorafenib—ABCB1—cardiovascular system—hypothyroidism	0.00029	0.00104	CbGeAlD
Regorafenib—ABCB1—gonad—hypothyroidism	0.000263	0.000944	CbGeAlD
Regorafenib—ABCB1—pituitary gland—hypothyroidism	0.000257	0.000921	CbGeAlD
Regorafenib—CYP3A4—liver—hypothyroidism	0.000253	0.000909	CbGeAlD
Regorafenib—ABCB1—adrenal gland—hypothyroidism	0.000229	0.000823	CbGeAlD
Regorafenib—ABCB1—blood—hypothyroidism	0.000229	0.000823	CbGeAlD
Regorafenib—ABCB1—thyroid gland—hypothyroidism	0.000221	0.000794	CbGeAlD
Regorafenib—ABCB1—female gonad—hypothyroidism	0.000214	0.000768	CbGeAlD
Regorafenib—ABCB1—testis—hypothyroidism	0.00019	0.000681	CbGeAlD
Regorafenib—ABCB1—liver—hypothyroidism	0.000179	0.000644	CbGeAlD
Regorafenib—ABCB1—cerebellum—hypothyroidism	0.000175	0.000629	CbGeAlD
Regorafenib—RAF1—Hemostasis—SH2B3—hypothyroidism	0.000127	0.000707	CbGpPWpGaD
Regorafenib—RAF1—Axon guidance—VAV3—hypothyroidism	0.000124	0.000694	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TSHB—hypothyroidism	0.000123	0.000686	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TSHR—hypothyroidism	0.000123	0.000686	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CLTC—hypothyroidism	0.000121	0.000675	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CLTC—hypothyroidism	0.00012	0.000673	CbGpPWpGaD
Regorafenib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00012	0.00067	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000119	0.000662	CbGpPWpGaD
Regorafenib—RAF1—Focal Adhesion—IGF1—hypothyroidism	0.000117	0.000655	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000117	0.000652	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ATP5O—hypothyroidism	0.000115	0.000645	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—VAV3—hypothyroidism	0.000114	0.000638	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CLTC—hypothyroidism	0.000112	0.000627	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—VAV3—hypothyroidism	0.000111	0.000618	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—SH2B3—hypothyroidism	0.00011	0.000612	CbGpPWpGaD
Regorafenib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000109	0.000611	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—PRL—hypothyroidism	0.000109	0.000608	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000109	0.000607	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—TPO—hypothyroidism	0.000109	0.000606	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CLTC—hypothyroidism	0.000109	0.000606	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CLTC—hypothyroidism	0.000106	0.000593	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CLTC—hypothyroidism	0.000106	0.000591	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—VAV3—hypothyroidism	0.000105	0.000586	CbGpPWpGaD
Regorafenib—RAF1—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000104	0.00058	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—VAV3—hypothyroidism	0.000103	0.000575	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—VAV3—hypothyroidism	0.000101	0.000563	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—IYD—hypothyroidism	9.96e-05	0.000556	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—VAV3—hypothyroidism	9.77e-05	0.000546	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—VAV3—hypothyroidism	9.75e-05	0.000544	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—AVP—hypothyroidism	9.71e-05	0.000542	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TRH—hypothyroidism	9.71e-05	0.000542	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—VAV3—hypothyroidism	9.69e-05	0.000541	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CLTC—hypothyroidism	9.68e-05	0.00054	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—VAV3—hypothyroidism	9.51e-05	0.000531	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	9.21e-05	0.000514	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TRH—hypothyroidism	9.17e-05	0.000512	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—TRH—hypothyroidism	9.15e-05	0.000511	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CLTC—hypothyroidism	9.13e-05	0.00051	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CLTC—hypothyroidism	9.04e-05	0.000505	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	9e-05	0.000503	CbGpPWpGaD
Regorafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	8.9e-05	0.000497	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—VAV3—hypothyroidism	8.86e-05	0.000495	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—VAV3—hypothyroidism	8.78e-05	0.00049	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—VAV3—hypothyroidism	8.69e-05	0.000486	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TSHR—hypothyroidism	8.65e-05	0.000483	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TSHB—hypothyroidism	8.65e-05	0.000483	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—VAV3—hypothyroidism	8.56e-05	0.000478	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ATP5O—hypothyroidism	8.47e-05	0.000473	CbGpPWpGaD
Regorafenib—CYP2B6—Biological oxidations—POMC—hypothyroidism	8.44e-05	0.000471	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—IYD—hypothyroidism	8.43e-05	0.000471	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CLTC—hypothyroidism	8.38e-05	0.000468	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CLTC—hypothyroidism	8.23e-05	0.00046	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TSHB—hypothyroidism	8.18e-05	0.000457	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TSHR—hypothyroidism	8.18e-05	0.000457	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—TSHB—hypothyroidism	8.16e-05	0.000456	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—TSHR—hypothyroidism	8.16e-05	0.000456	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—PRL—hypothyroidism	8.13e-05	0.000454	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.03e-05	0.000449	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—TPO—hypothyroidism	7.96e-05	0.000444	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TRH—hypothyroidism	7.89e-05	0.000441	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—POMC—hypothyroidism	7.84e-05	0.000438	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—VAV3—hypothyroidism	7.83e-05	0.000437	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TRH—hypothyroidism	7.81e-05	0.000436	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CLTC—hypothyroidism	7.81e-05	0.000436	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CLTC—hypothyroidism	7.79e-05	0.000435	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—SH2B3—hypothyroidism	7.71e-05	0.000431	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—IYD—hypothyroidism	7.52e-05	0.00042	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—VAV3—hypothyroidism	7.52e-05	0.00042	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—IYD—hypothyroidism	7.34e-05	0.00041	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—SH2B3—hypothyroidism	7.29e-05	0.000407	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—AVP—hypothyroidism	7.25e-05	0.000405	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TRH—hypothyroidism	7.24e-05	0.000404	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—AVP—hypothyroidism	7.24e-05	0.000404	CbGpPWpGaD
Regorafenib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.22e-05	0.000403	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—PRL—hypothyroidism	7.19e-05	0.000402	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ATP5O—hypothyroidism	7.17e-05	0.0004	CbGpPWpGaD
Regorafenib—CYP2C8—Biological oxidations—POMC—hypothyroidism	7.14e-05	0.000399	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TRH—hypothyroidism	7.11e-05	0.000397	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TSHB—hypothyroidism	7.03e-05	0.000393	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TSHR—hypothyroidism	7.03e-05	0.000393	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CLTC—hypothyroidism	7.02e-05	0.000392	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TSHB—hypothyroidism	6.96e-05	0.000389	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TSHR—hypothyroidism	6.96e-05	0.000389	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—IYD—hypothyroidism	6.86e-05	0.000383	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TRH—hypothyroidism	6.75e-05	0.000377	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—TPO—hypothyroidism	6.74e-05	0.000376	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TRH—hypothyroidism	6.73e-05	0.000376	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—VAV3—hypothyroidism	6.65e-05	0.000371	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—PRL—hypothyroidism	6.6e-05	0.000369	CbGpPWpGaD
Regorafenib—BRAF—Disease—PRL—hypothyroidism	6.58e-05	0.000367	CbGpPWpGaD
Regorafenib—KIT—Immune System—PRL—hypothyroidism	6.48e-05	0.000362	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TSHB—hypothyroidism	6.46e-05	0.00036	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TSHR—hypothyroidism	6.46e-05	0.00036	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—POMC—hypothyroidism	6.45e-05	0.00036	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ATP5O—hypothyroidism	6.4e-05	0.000357	CbGpPWpGaD
Regorafenib—CYP2C19—Biological oxidations—POMC—hypothyroidism	6.38e-05	0.000356	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TSHR—hypothyroidism	6.34e-05	0.000354	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TSHB—hypothyroidism	6.34e-05	0.000354	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—AVP—hypothyroidism	6.33e-05	0.000353	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—SH2B3—hypothyroidism	6.27e-05	0.00035	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CLTC—hypothyroidism	6.26e-05	0.000349	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ATP5O—hypothyroidism	6.24e-05	0.000349	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.24e-05	0.000349	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—SH2B3—hypothyroidism	6.21e-05	0.000347	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—IGF1—hypothyroidism	6.21e-05	0.000347	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—PRL—hypothyroidism	6.15e-05	0.000344	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—PRL—hypothyroidism	6.14e-05	0.000343	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—VAV3—hypothyroidism	6.11e-05	0.000341	CbGpPWpGaD
Regorafenib—FGFR2—Disease—PRL—hypothyroidism	6.1e-05	0.00034	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TRH—hypothyroidism	6.07e-05	0.000339	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TSHB—hypothyroidism	6.02e-05	0.000336	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TSHR—hypothyroidism	6.02e-05	0.000336	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—TPO—hypothyroidism	6.01e-05	0.000336	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TSHB—hypothyroidism	6e-05	0.000335	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TSHR—hypothyroidism	6e-05	0.000335	CbGpPWpGaD
Regorafenib—KIT—Immune System—VAV3—hypothyroidism	6e-05	0.000335	CbGpPWpGaD
Regorafenib—KIT—Disease—PRL—hypothyroidism	5.99e-05	0.000334	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—TSHB—hypothyroidism	5.92e-05	0.000331	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—TSHB—hypothyroidism	5.92e-05	0.000331	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—TPO—hypothyroidism	5.87e-05	0.000328	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—IGF1—hypothyroidism	5.85e-05	0.000327	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ATP5O—hypothyroidism	5.83e-05	0.000326	CbGpPWpGaD
Regorafenib—CYP2C9—Biological oxidations—POMC—hypothyroidism	5.81e-05	0.000325	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—SH2B3—hypothyroidism	5.75e-05	0.000321	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—PRL—hypothyroidism	5.72e-05	0.000319	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—VAV3—hypothyroidism	5.69e-05	0.000318	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PRL—hypothyroidism	5.68e-05	0.000317	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—VAV3—hypothyroidism	5.68e-05	0.000317	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PRL—hypothyroidism	5.67e-05	0.000316	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—SH2B3—hypothyroidism	5.65e-05	0.000316	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.57e-05	0.000311	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PRL—hypothyroidism	5.53e-05	0.000309	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	5.51e-05	0.000307	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—TPO—hypothyroidism	5.48e-05	0.000306	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TSHR—hypothyroidism	5.41e-05	0.000302	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TRH—hypothyroidism	5.41e-05	0.000302	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TSHB—hypothyroidism	5.41e-05	0.000302	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PRL—hypothyroidism	5.41e-05	0.000302	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PRL—hypothyroidism	5.39e-05	0.000301	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—SH2B3—hypothyroidism	5.36e-05	0.000299	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—IGF1—hypothyroidism	5.35e-05	0.000299	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—SH2B3—hypothyroidism	5.35e-05	0.000299	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—VAV3—hypothyroidism	5.29e-05	0.000296	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PIK3C2A—hypothyroidism	5.28e-05	0.000295	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PIK3C2A—hypothyroidism	5.28e-05	0.000295	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.21e-05	0.000291	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—VAV3—hypothyroidism	5.12e-05	0.000286	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PRL—hypothyroidism	5.11e-05	0.000285	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—AVP—hypothyroidism	5.1e-05	0.000285	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.08e-05	0.000284	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—TSHB—hypothyroidism	5.03e-05	0.000281	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—VAV3—hypothyroidism	5e-05	0.000279	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—VAV3—hypothyroidism	4.99e-05	0.000279	CbGpPWpGaD
Regorafenib—ABL1—Immune System—VAV3—hypothyroidism	4.98e-05	0.000278	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PRL—hypothyroidism	4.93e-05	0.000275	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—AVP—hypothyroidism	4.82e-05	0.000269	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—SH2B3—hypothyroidism	4.82e-05	0.000269	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TSHR—hypothyroidism	4.82e-05	0.000269	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TSHB—hypothyroidism	4.82e-05	0.000269	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—POMC—hypothyroidism	4.81e-05	0.000269	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—AVP—hypothyroidism	4.81e-05	0.000268	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PRL—hypothyroidism	4.65e-05	0.00026	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IGF1—hypothyroidism	4.63e-05	0.000259	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PRL—hypothyroidism	4.61e-05	0.000257	CbGpPWpGaD
Regorafenib—RAF1—Immune System—VAV3—hypothyroidism	4.56e-05	0.000255	CbGpPWpGaD
Regorafenib—RAF1—Disease—PRL—hypothyroidism	4.55e-05	0.000254	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—IYD—hypothyroidism	4.52e-05	0.000253	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PIK3C2A—hypothyroidism	4.48e-05	0.00025	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—SLC5A5—hypothyroidism	4.43e-05	0.000248	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—SLC5A5—hypothyroidism	4.43e-05	0.000248	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.34e-05	0.000243	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—VAV3—hypothyroidism	4.3e-05	0.00024	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—SH2B3—hypothyroidism	4.29e-05	0.00024	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PRL—hypothyroidism	4.27e-05	0.000238	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—VAV3—hypothyroidism	4.26e-05	0.000238	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PRL—hypothyroidism	4.19e-05	0.000234	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—AVP—hypothyroidism	4.14e-05	0.000231	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—AVP—hypothyroidism	4.1e-05	0.000229	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PRL—hypothyroidism	3.98e-05	0.000222	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PRL—hypothyroidism	3.97e-05	0.000222	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—VAV3—hypothyroidism	3.95e-05	0.000221	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—VAV3—hypothyroidism	3.88e-05	0.000217	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ATP5O—hypothyroidism	3.85e-05	0.000215	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—POMC—hypothyroidism	3.83e-05	0.000214	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—AVP—hypothyroidism	3.8e-05	0.000212	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—SLC5A5—hypothyroidism	3.76e-05	0.00021	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—AVP—hypothyroidism	3.74e-05	0.000209	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—TSHB—hypothyroidism	3.68e-05	0.000206	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—VAV3—hypothyroidism	3.68e-05	0.000206	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—VAV3—hypothyroidism	3.67e-05	0.000205	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—TPO—hypothyroidism	3.62e-05	0.000202	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PRL—hypothyroidism	3.57e-05	0.0002	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—AVP—hypothyroidism	3.55e-05	0.000198	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—AVP—hypothyroidism	3.54e-05	0.000198	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	3.42e-05	0.000191	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—POMC—hypothyroidism	3.39e-05	0.000189	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—VAV3—hypothyroidism	3.31e-05	0.000185	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	3.28e-05	0.000183	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IGF1—hypothyroidism	3.26e-05	0.000182	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—POMC—hypothyroidism	3.2e-05	0.000179	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—POMC—hypothyroidism	3.19e-05	0.000178	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—AVP—hypothyroidism	3.19e-05	0.000178	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PRL—hypothyroidism	3.19e-05	0.000178	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—TSHB—hypothyroidism	3.12e-05	0.000174	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IGF1—hypothyroidism	3.08e-05	0.000172	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—VAV3—hypothyroidism	2.95e-05	0.000165	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—AVP—hypothyroidism	2.84e-05	0.000159	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—TSHB—hypothyroidism	2.78e-05	0.000155	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	2.78e-05	0.000155	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—SLC5A5—hypothyroidism	2.76e-05	0.000154	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—POMC—hypothyroidism	2.75e-05	0.000154	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.74e-05	0.000153	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—POMC—hypothyroidism	2.73e-05	0.000152	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—TSHB—hypothyroidism	2.72e-05	0.000152	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IGF1—hypothyroidism	2.65e-05	0.000148	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IGF1—hypothyroidism	2.62e-05	0.000147	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—TSHB—hypothyroidism	2.54e-05	0.000142	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—POMC—hypothyroidism	2.53e-05	0.000141	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—POMC—hypothyroidism	2.48e-05	0.000139	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	2.48e-05	0.000139	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.45e-05	0.000137	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IGF1—hypothyroidism	2.43e-05	0.000136	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PIK3C2A—hypothyroidism	2.42e-05	0.000135	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IGF1—hypothyroidism	2.39e-05	0.000133	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—POMC—hypothyroidism	2.36e-05	0.000132	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—POMC—hypothyroidism	2.35e-05	0.000131	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—SLC5A5—hypothyroidism	2.34e-05	0.00013	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—POMC—hypothyroidism	2.32e-05	0.00013	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—POMC—hypothyroidism	2.32e-05	0.00013	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IGF1—hypothyroidism	2.27e-05	0.000127	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	2.26e-05	0.000126	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IGF1—hypothyroidism	2.26e-05	0.000126	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.23e-05	0.000125	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—POMC—hypothyroidism	2.12e-05	0.000118	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—SLC5A5—hypothyroidism	2.08e-05	0.000116	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IGF1—hypothyroidism	2.04e-05	0.000114	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.03e-05	0.000114	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—POMC—hypothyroidism	1.97e-05	0.00011	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—SLC5A5—hypothyroidism	1.9e-05	0.000106	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—POMC—hypothyroidism	1.89e-05	0.000105	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IGF1—hypothyroidism	1.82e-05	0.000101	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—TSHB—hypothyroidism	1.67e-05	9.35e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.49e-05	8.33e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—POMC—hypothyroidism	1.44e-05	8.06e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.25e-05	7e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—POMC—hypothyroidism	1.22e-05	6.82e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—POMC—hypothyroidism	1.09e-05	6.09e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—POMC—hypothyroidism	1.06e-05	5.94e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—POMC—hypothyroidism	9.94e-06	5.55e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—POMC—hypothyroidism	6.56e-06	3.66e-05	CbGpPWpGaD
